Seth van Voorhees - 15 Jun 2021 Form 4 Insider Report for PDS Biotechnology Corp (PDSB)

Role: Chief Financial Officer
Signature: /s/ Seth Van Voorhees
Issuer symbol: PDSB
Transactions as of: 15 Jun 2021
Net transactions value: +$150,000
Form type: 4
Filing time: 17 Jun 2021, 18:52:14 UTC
Next filing: 29 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PDSB	Common Stock	Purchase	$150,000	+17,647		$8.50	17,647	15 Jun 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of common stock purchased by the Reporting Person at the public offering price in connection with the Issuer's firm commitment underwritten public offering of common stock, which closed on June 17, 2021, and such shares of common stock are subject to a lock up agreement between the Reporting Person and Cantor Fitzgerald & Co., pursuant to which the shares cannot be sold for 90 days following June 15, 2021.

Content

Represents shares of common stock purchased by the Reporting Person at the public offering price in connection with the Issuer's firm commitment underwritten public offering of common stock, which closed on June 17, 2021, and such shares of common stock are subject to a lock up agreement between the Reporting Person and Cantor Fitzgerald & Co., pursuant to which the shares cannot be sold for 90 days following June 15, 2021.